Skip to main navigation Skip to search Skip to main content

Identification of Haptoglobin as a Readout of rhGH Therapy in GH Deficiency

Research output: Contribution to journalArticlepeer-review

Abstract

GH deficiency (GHD) is characterized by a cluster of cardiovascular risk factors and subtle inflammation. We aimed to demonstrate, through a proteomic approach, molecules directly modulated by GHD and involved in the inflammatory state.
Original languageEnglish
Pages (from-to)5263-5273
Number of pages11
JournalTHE JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Volume104
Issue number11
DOIs
Publication statusPublished - 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Identification of Haptoglobin as a Readout of rhGH Therapy in GH Deficiency'. Together they form a unique fingerprint.

Cite this